0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Safety and tolerability, wearing-off

Session 3: Safety and tolerability, wearing-off

Dagny Holle-Lee

MD, PhD, Professor, Westgerman Headache Center Essen, Germany

Download presentation

Previous

Targeting ion channels

Next

Combination therapy and switching

You Might Also Like

Related Embedded Video Item Thumbnail Clinical Implications
Related Embedded Video Item Thumbnail Intelligent digital technology in migraine management: examples from NTNU, Norway
Related Embedded Video Item Thumbnail Combination therapy and switching
Related Embedded Video Item Thumbnail Impact on patients
Related Embedded Video Item Thumbnail Epidemiological and clinical aspects

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct

Norway, Finland, Denmark: AJO-DK-NP-00128